Objective: To analyze the impact of COVID-19 in Parkinson cases and healthy controls from a Peruvian population.
Background: The COVID-19 pandemic have a profound impact affecting worldwide people´s lives. The stress caused by COVID-19 pandemic may has increased problems for patients with Parkinson Disease (PD). There are few data on effects of COVID-19 pandemic in motor and non-motor symptoms, perceptions and attitudes in Peruvian PD patients.
Method: Since May 2021, all participants, PD cases and healthy controls, recruited for a genetic association study in Peru were offered to complete an optional COVID19 impact survey developed by National Alzheimer’s coordinating Center. We analyze information provided by all respondents based on descriptive analysis.
Results: We analyzed a total of 115 COVID-19 surveys, 19 PD cases (median age 60.9 years, 13 men) and 96 healthy controls (median age 57.5 years, 32 men). A total of 4 PD cases and 29 healthy controls declared to have COVID-19 (p = 0.45, Fisher’s test). PD cases feel more worried than healthy controls about contracting COVID-19 (p = 0.004, Fisher’s test). PD cases feel more isolated than controls due to COVID-19 pandemic (p = 0.02, Fisher’s test). PD cases are less able than healthy controls to control important things in their lives (p = 0.02, Fisher’s test). PD-related symptoms worsened in the majority of PD cases (12/19 PD cases). The PD- related symptoms that worse more frequently were anxiety (82.3%), depression (71%), fatigue (66.7%) and sleep (61%).
Conclusion: There is not difference in the risk of contracting COVID-19 observed among cases and controls. Our results suggest the COVID-19 pandemic has affected Peruvian PD patients in many aspects, including PD-related symptoms especially non-motors symptoms.
References: 1. National Alzheimer’s coordinating Center. COVID19 impact survey. June, 2020
To cite this abstract in AMA style:E. Sarapura-Castro, D. Rivera-Asencios, M. Illanes-Manrique, A. Rivera-Valdivia, M. Inca-Martinez, K. Mejia-Rojas, J. Rios-Pinto, A. Medina-Colque, I. Cornejo-Herrera, E. Ochoa-Valle, C. Cosentino, I. Mata, M. Cornejo-Olivas. Impact of COVID-19 in Parkinson disease: preliminary analysis from a survey performed in a Peruvian PD cohort. [abstract]. Mov Disord. 2022; 37 (suppl 2). https://www.mdsabstracts.org/abstract/impact-of-covid-19-in-parkinson-disease-preliminary-analysis-from-a-survey-performed-in-a-peruvian-pd-cohort/. Accessed September 25, 2023.
« Back to 2022 International Congress
MDS Abstracts - https://www.mdsabstracts.org/abstract/impact-of-covid-19-in-parkinson-disease-preliminary-analysis-from-a-survey-performed-in-a-peruvian-pd-cohort/